Axena Health has announced a collaboration with Mayo Clinic to integrate overactive bladder educational content into its Leva Pelvic Health System. The partnership, which includes an investment from Mayo Clinic, aims to expand education and advance first-line care for female urinary incontinence.
The Leva System combines an FDA-cleared vaginal motion sensor with a smartphone app to provide at-home guided treatment for urinary incontinence through pelvic floor muscle training. The Mayo Clinic’s educational content will be available to all Leva users starting Spring 2025.
“Urinary incontinence impacts millions of women worldwide yet remains underdiagnosed and undertreated due in part to a lack of discussion and education about the condition,” said Randy Pritchard, CEO of Axena Health. “Our collaboration with Mayo Clinic underscores our commitment to empowering women to take control of their pelvic health through clinically proven treatments and accessible, evidence-based education.”
The collaboration aims to address knowledge gaps in pelvic health care. “Education is a cornerstone of effective care, particularly for conditions like urinary incontinence where stigma and misinformation often hinder treatment,” added Dr. Mandy Pulliam, Chief Medical Officer of Axena Health.
The Leva System, available by prescription only, offers a non-invasive, medication-free treatment option that can be used at home in five minutes daily. The system provides real-time visualization of pelvic movement and progress tracking, while maintaining physician involvement in treatment. Multiple clinical trials, including two studies in Obstetrics and Gynecology, support its efficacy in treating urinary incontinence.
